Compare PLNT & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | ELAN |
|---|---|---|
| Founded | 1992 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 11.6B |
| IPO Year | 2015 | 2018 |
| Metric | PLNT | ELAN |
|---|---|---|
| Price | $74.96 | $23.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $116.67 | $27.63 |
| AVG Volume (30 Days) | 2.0M | ★ 3.7M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,324,144,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $19.55 | $7.97 |
| Revenue Next Year | $11.83 | $5.21 |
| P/E Ratio | $38.47 | ★ N/A |
| Revenue Growth | ★ 12.06 | 6.22 |
| 52 Week Low | $73.32 | $8.02 |
| 52 Week High | $114.47 | $27.72 |
| Indicator | PLNT | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 30.93 | 42.21 |
| Support Level | N/A | $20.73 |
| Resistance Level | $113.11 | $25.68 |
| Average True Range (ATR) | 2.99 | 0.80 |
| MACD | -0.39 | -0.28 |
| Stochastic Oscillator | 16.30 | 17.36 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.